- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
卡维地洛对老年慢性心力衰竭患者心功能影响
卡维地洛对老年慢性心力衰竭患者心功能影响[摘要] 目的 研究卡维地洛或美托洛尔对老年慢性心力衰竭患者心功能的改善作用及对血清肾上腺素受体自身抗体(α、β1、β2)的影响。方法 将72例老年心衰患者随机分为A组和B组,在常规强心、利尿治疗的同时,分别应用卡维地洛和美托洛尔进行治疗,比较两组治疗前和治疗后6个月心脏超声指标和α、β1、β2受体自身抗体的变化。结果 两组的LVEDD、LVEDV、LVSDV值明显降低,LVEF值显著升高(P<0.05),且A组更优于B组(P<0.05),A组的抗α抗体、抗β1抗体、抗β2抗体阳性率均较治疗前显著降低(P<0.05),而B组仅抗β1抗体阳性率降低,余无差异(P>0.05)。结论 卡维地洛可有效改善心功能,提高心脏射血分数,改善心室重构,疗效优于美托洛尔,其机制可能与其持久地非选择性地阻断β1、β2受体和血管壁α1受体,使其最大限度地降低过度激活的神经内分泌因子介导的心肌毒性作用有关。
[关键词] 心力衰竭;肾上腺素能;自身抗体
[中图分类号] R541.6+1 [文献标识码] A [文章编号] 1673-9701(2011)24-01-03
The Effect of Carvedilol on Cardiac Function and Serum Adrenergic Receptor Autoantibodies of Elderly Patients with Chronic Heart Failure
WANG Lixia XU Hui
Department Ⅱof Internal Medicine,Zhuji City TCM Hospital,Zhuji 311800,China
[Abstract] Objective To study the effect of carvedilol or metoprolol on cardiac function and serum adrenergic receptor autoantibodies (α, β1, β2) of elderly patients with chronic heart failure. Methods All 72 cases elderly patients with heart failure were randomly divided into group A and group B, and A group and B group were treated with carvedilol and metoprolol respectively based on conventional treatment. After 6 months,cardiac echocardiography and α, β1, β2 receptor autoantibodies were compared. Results The two groups of LVEDD,LVEDV, LVSDV was significantly reduced, LVEF was significantly higher(P<0.05),and group A was better than group B(P<0.05),A group of anti-α antibody,anti-β1 antibody, anti-β2 antibody-positive rate was significantly lower than before treatment(P<0.05),while group B only anti-β1 antibody positive rate lower and had no difference(P>0.05). Conclusion Carvedilol can improve heart function,increase ejection fraction,improve ventricular remodeling,and be more effective than metoprolol,which may be sustained with non-selective blocking β1,β2 receptor and vascular wall α1 receptors,to minimize the excessive activation of neuroendocrine factors mediated cardiac toxicity related to the role.
[Key words] Heart fai
文档评论(0)